SS Innovations International (SSII) Share-based Compensation Growth (3y) (2019 - 2026)
SS Innovations International (SSII) Share-based Compensation Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 5.29% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.56% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 13.40% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | 58.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.32% |
| Dec 31, 2025 | 103.35% |
| Sep 30, 2025 | 42.44% |
| Jun 30, 2025 | 52.19% |
| Mar 31, 2025 | 338.39% |
| Dec 31, 2024 | 75.85% |
| Sep 30, 2024 | 352.01% |
| Jun 30, 2024 | 135.56% |
| Mar 31, 2024 | 244.02% |
| Dec 31, 2023 | 284.86% |
| Sep 30, 2023 | -51.43% |
| Jun 30, 2023 | -68.81% |
| Mar 31, 2023 | -121.91% |
| Dec 31, 2022 | -42.62% |
| Sep 30, 2022 | 245.28% |
| Jun 30, 2022 | 112.24% |
| Mar 31, 2022 | -16.42% |
| Dec 31, 2021 | 119.08% |
| Sep 30, 2021 | -17.11% |
| Jun 30, 2021 | 198.22% |